AUS
NZ
UK
CA
USA
IND
Health
Eli Lilly’s (NYSE: LLY) Zepbound (tirzepatide) Receives FDA Approval for Moderate-to-Severe Obstructive Sleep Apnea (OSA) and Obesity Treatment
December 22, 2024 09:09 PM PST| By Team Kalkine MediaHighlights,Zepbound (tirzepatide) is the first FDA-approved prescription for OSA with obesity.,Patients experienced up to 20% weight loss and 25 fewer breathing interruptions per hour.,Zepbound receives second FDA indication, expanding its potential...
UnitedHealth Group's (NYSE:UNH) Operational Efficiency and Market Presence
December 22, 2024 08:52 AM PST| By Team Kalkine MediaHighlights,UnitedHealth Group returns plateauing after strong performance.,ROCE remains stable at 16% despite increased capital employment.,Steady reinvestment of capital supports shareholder returns.,UnitedHealth Group's returns have plateaued recen...
Analyzing Haemonetics (NYSE:HAE) Earnings and Share Price Dynamics
December 20, 2024 11:46 AM PST| By Team Kalkine MediaHighlights,Haemonetics share price increase by 42% over three years,EPS growth of 59% per year outpaces share price increase,Market expectations for Haemonetics growth moderated,Haemonetics has shown impressive growth over the past three years, with...
Dental and Medical Innovations at Milestone Scientific (NYSE:MLSS)
December 20, 2024 09:22 AM PST| By Team Kalkine MediaHighlights,Increased holdings in Milestone Scientific by hedge funds and institutions.,Advanced injection technologies for medical, dental, and cosmetic use.,Operations span the U.S., China, and international markets.,Milestone Scientific, a pioneer...
Revenue and Share Price Trends for Arcus Biosciences (NYSE:RCUS)
December 20, 2024 09:03 AM PST| By Team Kalkine MediaHighlights,Arcus Biosciences stock drops 9.9% this week.,Shareholders face a 65% decline over three years.,Revenue has been decreasing by 14% annually.,Amid the dynamic landscape of the,NYSE Healthcare Stocks,sector, Arcus Biosciences has faced a tou...
Why Boston Scientific (NYSE:BSX) Stands Out Among Healthcare Stocks.
December 20, 2024 08:20 AM PST| By Team Kalkine MediaHighlights,16% annual EPS growth over the past three years.,Strong revenue growth and high EBIT margin.,Insider ownership aligns management with shareholders.,Boston Scientific Corp. stands out among,NYSE Healthcare Stocks,with its consistent perform...
Tracking the Performance of Emergent BioSolutions (NYSE:EBS) in the Market
December 20, 2024 08:20 AM PST| By Team Kalkine MediaHighlights,Emergent BioSolutions sees increased institutional interest.,Stock performance reflects recent fluctuations with a 12-month range of $1.42 to $15.10.,Life sciences companies provide public health solutions.,Emergent BioSolution plays a piv...
Cencora Gains Positive Analyst Sentiment and Price Target Revisions
December 20, 2024 02:33 AM PST| By Team Kalkine MediaHeadlines,Analysts have shown confidence in Cencora's future performance.,Price targets for Cencora show positive growth expectations.,Several major firms have raised their price targets for Cencora.,Cencora, Inc.,(NYSE:COR),has attracted significant...
Why Did Taysha Gene Therapies Stock Drop Below Its Moving Average?
December 20, 2024 01:04 AM PST| By Team Kalkine MediaHighlights,Taysha Gene Therapies focuses on innovative genetic treatments.,Recent stock performance shows fluctuations in moving averages.,Current financials highlight a strong liquidity position.,Taysha Gene Therapies,(NASDAQ:TSHA),operates within t...
Why Is Hims & Hers Health Facing Market Uncertainty This Week?
December 20, 2024 12:40 AM PST| By Team Kalkine MediaHighlights,Hims & Hers operates in the telehealth and wellness sector.,The company offers personalized solutions in healthcare services.,Key focus on mental health, dermatology, and primary care solutions.,The telehealth sector has grown significantl...
Why Are Insiders Rapidly Reducing Their Stake in PTC Therapeutics?
December 20, 2024 12:33 AM PST| By Team Kalkine MediaHighlights,PTC Therapeutics focuses on rare diseases in the biopharmaceutical sector.,Institutional investors have increased holdings, showcasing interest in the company.,Insider transactions show significant shifts in ownership over recent months.,P...
Is AVITA's New FDA Clearance a Game-Changer for Wound Care?
December 20, 2024 12:30 AM PST| By Team Kalkine MediaHighlights,AVITA Medical gains FDA clearance for Cohealyx, a dermal matrix product.,Cohealyx enhances tissue integration for full-thickness wound treatment.,Clinical studies and commercialization set for 2025 launch phases.,AVITA Medical,(NASDAQ:RCEL...
Why Did Bicycle Therapeutics Shares Drop After Recent Price Target Revision?
December 20, 2024 12:25 AM PST| By Team Kalkine MediaHighlights,Bicycle Therapeutics plc focuses on developing targeted therapies for diseases.,JMP Securities adjusted its price target while maintaining its market outperform rating.,Trading volume showed a significant decrease compared to the stock’s a...
What Sets SYMVESS Apart in Urgent Vascular Repair?
December 20, 2024 12:23 AM PST| By Team Kalkine MediaHighlights,FDA approves SYMVESS for urgent arterial injury treatment.,Clinical trials show high patency and low complication rates.,SYMVESS eliminates the need for vein harvesting in trauma cases.,The healthcare sector has seen a significant advancem...
What Is Dragging Arrowhead Pharmaceuticals, Inc Down in Market Sentiment?
December 20, 2024 12:11 AM PST| By Team Kalkine MediaHighlights,Arrowhead Pharmaceuticals announces new employment-related equity grants.,Grants cover 44,350 restricted stock units for 20 new employees.,Vesting schedule set annually over four years outside approved plans.,Arrowhead Pharmaceuticals, Inc...
Teleflex:Institutional Interest Remains Strong Despite Adjustments
December 19, 2024 08:54 PM PST| By Team Kalkine MediaHeadlines,Jane Street Group LLC reduces its stake in Teleflex,Several institutional investors increase positions in the medical technology company,Hedge funds hold the majority of Teleflex shares,Jane Street Group LLC has reduced its position in Tele...
Pediatrix Medical Group Receives Target Price Revisions Amid Positive Earnings Growth
December 19, 2024 03:27 AM PST| By Team Kalkine MediaHeadlines,Pediatrix Medical Group receives updated target price from various analysts.,Quarterly earnings report surpasses expectations with positive revenue growth.,Stock shows significant movement in recent trading sessions.,Pediatrix Medical Group...
Prothena Corporation plc (NASDAQ: PRTA) Announces Phase IIb PADOVA Study Results for Prasinezumab in Parkinson’s Disease
December 19, 2024 12:29 AM PST| By Team Kalkine MediaHighlights,Prasinezumab demonstrates potential to slow motor progression in early-stage Parkinson's disease.,Subgroup analysis of levodopa-treated patients shows significant improvement with prasinezumab.,Prothena aims for first-in-class disease-modi...
Why Did This Parkinson's Drug Trial Fail to Hit Its Mark?
December 19, 2024 12:15 AM PST| By Team Kalkine MediaHighlights,Prothena develops treatments targeting neurodegenerative diseases.,PADOVA study explored prasinezumab for early Parkinson’s disease treatment.,Results highlight key findings in motor progression delay.,Prothena,(NASDAQ:PRTA),operates in th...
Is Oramed Pharmaceuticals Facing Uncertainty Despite a Positive Trading Day?
December 19, 2024 12:05 AM PST| By Team Kalkine MediaHighlights,Oramed Pharmaceuticals focuses on innovative oral drug delivery systems.,The stock is within the biotechnology and healthcare sectors.,Key data includes market trends and current trading statistics.,The biotechnology sector has seen signif...
